Specifically, IL-6 is a central mediator in the pathogenesis of chronic inflammatory disorders, autoimmune diseases, cancer, and cytokine storms [45,46]; our experimental data showed that COP supplementation significantly reduced serum IL-6 levels in Wenchang chicks, suggesting a direct inhibitory effect on this critical proinflammatory cytokine. Here, IL6 is linked to cancer.